How ProQR Therapeutics NV (PRQR) Stacks Up Against Its Peers

We view hedge fund activity in the stock as unfavorable, but in this case there was only a single hedge fund selling its entire position: Renaissance Technologies. One hedge fund selling its entire position doesn’t always imply a bearish intent. Theoretically a hedge fund may decide to sell a promising position in order to invest the proceeds in a more promising idea. However, we don’t think this is the case in this case because none of the 700+ hedge funds tracked by Insider Monkey identified PRQR as a viable investment and initiated a position in the stock.

Let’s also examine hedge fund activity in other stocks similar to ProQR Therapeutics NV (NASDAQ:PRQR). We will take a look at Lawson Products, Inc. (NASDAQ:LAWS), Black Diamond Inc (NASDAQ:BDE), Proteon Therapeutics Inc (NASDAQ:PRTO), and Republic First Bancorp, Inc. (NASDAQ:FRBK). This group of stocks’ market caps resemble PRQR’s market cap.

As you can see these stocks had an average of 5 hedge funds with bullish positions and the average amount invested in these stocks was $18 million. That figure was $28 million in PRQR’s case. Black Diamond Inc (NASDAQ:BDE) is the most popular stock in this table. On the other hand Lawson Products, Inc. (NASDAQ:LAWS) is the least popular one with only 3 bullish hedge fund positions. ProQR Therapeutics NV (NASDAQ:PRQR) is not the most popular stock in this group but hedge fund interest is still above average. This is a slightly positive signal but we’d rather spend our time researching stocks that hedge funds are piling on. In this regard BDE might be a better candidate to consider taking a long position in.

Disclosure: None